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Degradation or “down-regulation” of protease-activated receptor-1 (PAR1), a G protein-coupled
receptor for thrombin, is critical for termination of receptor signaling. Toward understanding the
molecular mechanisms by which activated PAR1 is internalized, sorted to lysosomes, and de-
graded, we investigated whether PAR1 interacted with sorting nexin 1 (SNX1). SNX1 is a
membrane-associated protein that functions in lysosomal sorting of the epidermal growth factor
receptor. In vitro biochemical binding assays revealed a specific interaction between a glutathione
S-transferase fusion of SNX1 and PAR1. In HeLa cells, activated PAR1 colocalized with endoge-
nous SNX1 and coimmunoprecipitated SNX1. SNX1 contains a phox homology domain predicted
to bind phosphatidylinositol-3-phosphate and a C-terminal coiled-coil region. To assess SNX1
function, we examined the effects of SNX1 deletion mutants on PAR1 trafficking. Neither the N
terminus nor phox homology domain of SNX1 affected PAR1 trafficking. By contrast, overexpres-
sion of SNX1 C-terminal domain markedly inhibited agonist-induced degradation of PAR1,
whereas internalization remained virtually intact. Immunofluorescence microscopy studies re-
vealed substantial PAR1 accumulation in an early endosome antigen-1-positive compartment in
agonist-treated cells expressing SNX1 C terminus. By contrast, lysosome-associated membrane
protein-1 distribution was unperturbed. Together, these findings strongly suggest a role for SNX1 in
sorting of PAR1 from early endosomes to lysosomes. Moreover, this study provides the first example
of a protein involved in lysosomal sorting of a G protein-coupled receptor in mammalian cells.
INTRODUCTION
The precise regulation of G protein-coupled receptor (GPCR)
signaling is critical for a variety of physiological responses. The
2-adrenergic receptor has served as a model system to eluci-
date the molecular mechanisms responsible for desensitization
and resensitization of GPCR signaling (Krupnick and Benovic,
1998; Lefkowitz et al., 1998). Desensitization, internalization,
and down-regulation, three temporarily distinct processes, me-
diate termination of GPCR signaling. Activated GPCRs are
initially desensitized by rapid phosphorylation and binding of
arrestins, which uncouples the receptor from G proteins. Ar-
restins also facilitate GPCR internalization, thereby removing
the receptor from the cell surface. Once internalized into endo-
somes, receptors are either recycled back to the cell surface or
sorted to lysosomes and degraded. The molecular mechanisms
mediating GPCR degradation or down-regulation by traffick-
ing of internalized receptors from endosomes to lysosomes
remains poorly understood.
The importance of down-regulation in the regulation of
GPCR signaling is best understood for protease-activated
receptor-1 (PAR1). PAR1, a GPCR for the coagulant protease
thrombin, elicits a variety of signaling events important for
hemostasis, thrombosis, and embryonic development
(Coughlin, 2000; Griffin et al., 2001). PAR1 is activated by an
unusual proteolytic mechanism. Thrombin binds to and
cleaves PAR1’s extracellular amino terminus, creating a new
amino terminus that functions as a tethered ligand (Vu et al.,
1991a). A synthetic peptide, SFLLRN, which represents
PAR1’s newly formed amino terminus, can fully activate the
receptor, independent of thrombin and receptor cleavage
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(Vu et al., 1991b; Scarborough et al., 1992; Vassallo et al.,
1992). Activated PAR1 is then rapidly internalized, sorted to
lysosomes, and degraded with a half-life of 30 min (Hein
et al., 1994; Woolkalis et al., 1995; Trejo and Coughlin, 1999).
In fibroblasts, a mutant PAR1 able to internalize and recycle
back to the cell surface shows enhanced and prolonged
signaling after activation with thrombin (Trejo et al., 1998;
Trejo and Coughlin, 1999). This prolonged signaling is ap-
parently due to recycling and continued signaling by recep-
tors that return to the plasma membrane with their tethered
ligands intact. These studies strongly suggest that the down-
regulation of activated PAR1 by internalization and lysoso-
mal sorting is critical for termination of receptor signaling.
The efficiency by which activated PAR1 is internalized
and sorted to lysosomes suggests that it might be a useful
system for elucidating the molecular mechanisms responsi-
ble for GPCR down-regulation. We previously demon-
strated that PAR1 is internalized by a dynamin- and clath-
rin-dependent pathway like recycling receptors (Trejo et al.,
2000). Activated PAR1 is recruited to clathrin-coated pits,
where it colocalizes with transferrin receptor. Dominant-
negative dynamin and clathrin hub mutants both block ag-
onist-induced PAR1 internalization. Moreover, inhibition of
PAR1 internalization by dynamin (K44A) mutant blocks
agonist-induced degradation. Interestingly, we recently
showed that PAR1 internalization through a dynamin- and
clathrin-dependent pathway is independent of arrestins
(Paing et al., 2002). The mechanism by which activated PAR1
is recruited to clathrin-coated pits, internalized, and sorted
to lysosomes remains unknown.
Sorting nexin 1 (SNX1) was originally identified as a pro-
tein that interacts with the epidermal growth factor receptor
(EGF-R) (Kurten et al., 1996). EGF-R degradation was en-
hanced in cells overexpressing SNX1, suggesting a role in
endosome-to-lysosome trafficking. Moreover, SNX1 interac-
tion with the EGF-R cytoplasmic tail lysosomal sorting se-
quence is required for down-regulation. The yeast ortholog
of SNX1, Vps5p, is part of a multimeric retromer complex
that functions in endosome-to-Golgi retrieval of a sorting
receptor that mediates efficient delivery of hydrolases to the
vacuole, an organelle analogous structurally and function-
ally to the mammalian lysosome (Horazdovsky et al., 1997;
Nothwehr and Hindes, 1997; Seaman et al., 1998). SNX1 has
also been shown to be part of a large multimeric complex in
mammalian cells, suggesting a similar function in cargo
selection and vesicle formation perhaps as part of the endo-
some-to-lysosome sorting machinery (Haft et al., 2000). To-
ward understanding the molecular mechanisms by which
PAR1 is down-regulated, we investigated whether PAR1
interacts with SNX1. In this study, we report that SNX1
associates with PAR1 and regulates agonist-induced degra-
dation of the receptor. These studies reveal a new role for
SNX1 in sorting of PAR1 from early endosomes to lyso-
somes and provide the first example of a protein involved in
lysosomal sorting of a GPCR in mammalian cells.
MATERIALS AND METHODS
Materials and Antibodies
Agonist peptide SFLLRN was synthesized as the carboxyl amide
and was purified by high-pressure liquid chromatography (Univer-
sity of North Carolina, Chapel Hill Peptide Facility). ATP was from
Sigma (St. Louis, MO). Monoclonal anti-c-myc-peroxidase antibody
was purchased from Roche Molecular Biochemicals (Indianapolis,
IN). M1 and M2 anti-FLAG monoclonal antibodies (mAbs) were
purchased from Sigma. Anti-mouse immunoglobulin G (IgG) was
from Pierce (Rockford, IL). Antihemagglutinin (HA) mAb (HA.11)
was purchased from Covance (Richmond, CA). Anti-PAR1 1809
rabbit polyclonal antibody was generously provided by Shaun R.
Coughlin (University of California, San Francisco) (Hung et al.,
1992). Rabbit polyclonal anti-c-myc antibody (A-14) and mouse
anti-myc antibody (9E10) were purchased from Santa Cruz Biotech-
nology (Santa Cruz, CA). Chicken anti-c-myc IgY antibody was
obtained from Molecular Probes (Eugene, OR). SNX1 antiserum was
generated as described (Haft et al., 2000). Mouse antiearly endosome
antigen-1 (EEA1) antibody was purchased from Transduction Lab-
oratories (San Diego, CA). Antilysosome-associated membrane pro-
tein-1 (lamp1) H4A3 mAb was obtained from the Developmental
Studies Hybridoma Bank maintained by the University of Iowa
(Department of Biological Sciences, Iowa City). Secondary antibod-
ies goat anti-mouse and anti-rabbit conjugated to horseradish per-
oxidase were purchased from Bio-Rad (Richmond, CA). Al-
exa™488- and Alexa™594-conjugated goat anti-mouse and anti-
rabbit antibodies, and Alexa™647-conjugated goat anti-chicken
antibodies were from Molecular Probes.
cDNAs and Cell Lines
A PAR1 cDNA containing an amino-terminal FLAG sequence
(DYKDDDD) has been described (Ishii et al., 1993). The P2Y2 recep-
tor bearing an amino-terminal HA (YPYDVPDYA) tag was gener-
ously provided by T. Kendall Harden (University of North Carolina,
Chapel Hill) (Sromek and Harden, 1998). N-terminal c-myc- and
HA-tagged SNX1 constructs were previously described (Haft et al.,
1998). SNX1 deletion mutants were generated by polymerase chain
reaction (PCR), cloned into pcDNA3.1 (Invitrogen, Carlsbad, CA),
and yielded an N terminus consisting of residues 1–160, N-PX
domain contained residues 1–273, and PX-C terminus contained
residues 156–522. The C-terminal domain generated by PCR con-
sisted of residues 273–522 and was cloned into pCMV5 (Andersson
et al., 1989). All SNX1 deletion mutants contained an N-terminal
c-myc epitope tag and were confirmed by dideoxy sequencing.
HeLa cells were maintained in DMEM supplemented with 10% fetal
bovine serum, 4.5 mg/ml glucose, 100 U/ml penicillin, and 100
l/ml streptomycin. HeLa cells stably expressing FLAG-tagged
PAR1 were previously described (Trejo et al., 2000).
SNX1 In Vitro Binding Assays
The entire coding region of SNX1 was cloned into pGEX-5X-1 vector
(Amersham Pharmacia Biotech, Piscataway, NJ) and was used to
generate GST-SNX1 fusion protein. Constructs were transformed
into BL21DE3 Escherichia coli, and proteins were induced and puri-
fied using standard techniques. Crude membranes were prepared
from HeLa cells stably expressing PAR1 or transiently expressing
HA-P2Y2 receptor and untransfected (UT) control cells using a
previously described procedure (Sarkadi et al., 1992). Briefly, cells
plated in 100-mm dishes (Falcon) were collected and Dounce ho-
mogenized in 50 mM Tris-HCl, pH 7, 50 mM mannitol, and 2 mM
EGTA (TMEP) containing protease inhibitors. The undisrupted cells
were removed by centrifugation at 500  g for 10 min, and the
supernatant was then centrifuged at 100,000  g for 1 h at 4°C. The
pelleted membranes were resuspended in TMEP and protein con-
centrations were determined using BCA Protein Assay Reagent
(Pierce). Membrane preparations were stored at 80°C. For binding
assays, an 10 g of glutathione S-transferase (GST)-SNX1 fusion
protein or GST alone was immobilized on glutathione-Sepharose 4B
beads and then incubated with 30 g of crude membranes over-
night at 4°C in Binding Buffer-150 (50 mM Tris-HCl, pH 7, 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM MgCl2, 0.5 mM CaCl2, and
0.05% Triton X-100). Binding reactions were then washed twice with
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Binding Buffer-150 and once in Binding Buffer-500 (Binding Buffer-
150 supplemented with 500 mM NaCl). Proteins that remained
bound were eluted in 2 SDS-gel loading buffer (100 mM Tris-HCl,
pH 6.8, 10% SDS, 0.2% bromphenol blue, and 20% glycerol), re-
solved by SDS-PAGE, transferred to polyvinylidene difluoride
membrane (Bio-Rad) and immunoblotted with anti-PAR1 1809 an-
tibody or anti-HA antibody. Immunoblots were developed with
ECL-PLUS (Amersham Pharmacia Biotech, Arlington, IL) and im-
aged by autoradiography. The total amount of GST-SNX1 and GST
loaded in each lane was visualized by staining the membrane with
Ponceau S (Sigma) according to the manufacturer’s instructions.
Transient Transfections
HeLa cells were plated at 5  105 cells per well in 6-well dishes
(Falcon) or 0.5  105 cells per well in 24-well dishes (Falcon) and
grown overnight. Cells were then transiently transfected with a total
of 2 g of plasmid DNA per well of a 6-well dish or 0.4 g of
plasmid DNA per well of a 24-well dish using Lipofectamine Re-
agent according to the manufacturer’s instructions (Life Technolo-
gies, Grand Island, NY). All assays were performed 48 h after
transfections.
Coimmunoprecipitation
HeLa cells were transiently cotransfected with FLAG-tagged PAR1
and myc-tagged SNX1 cDNA constructs and grown for 48 h.
Transfected cells were incubated in the absence or presence of
agonist for 10 min at 37°C and were then lysed in 1% Triton X-100,
50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM EDTA, 50 mM NaF,
10 mM sodium pyrophosphate, and 200 M sodium orthovanadate
containing protease inhibitors. Protein concentrations were deter-
mined using BCA Protein Assay Reagent (Pierce), and equal
amounts of protein lysates were used for immunoprecipitation with
M2 anti-FLAG antibody or isotype-matched IgG control. HeLa cells
transiently cotransfected with HA-SNX1 and myc-SNX1 deletion
mutants were processed as described above and immunoprecipi-
tated with anti-HA antibody. Immunoprecipitates were resolved by
12% SDS-PAGE, transferred to a polyvinylidene difluoride mem-
brane, and immunoblotted with either anti-PAR1 1809 antibody or
anti-c-myc-peroxidase-conjugated antibody. The expression of the
various SNX constructs was determined by immunoblotting equiv-
alent amounts of cell lysates with anti-c-myc or anti-HA antibody.
Immunoblots were then developed with ECL-PLUS, imaged by
autoradiography, and quantitated using a Fluor-S Imager (Bio-Rad).
Cell-Surface ELISA
HeLa cells plated in 24-well dishes were transiently cotransfected,
grown for 48 h, and then treated in the absence or presence of
agonist for various times at 37°C. Following agonist treatment, cells
were fixed with 4% paraformaldehyde and the amount of PAR1 or
P2Y2 receptor remaining on the cell surface was measured by ELISA
as previously described (Paing et al., 2002).
Confocal Microscopy
HeLa cells plated on fibronectin-coated glass coverslips (22  22
mm) in 6-well dishes and were grown for 48 h. Cells were then
incubated with M1 anti-FLAG or anti-PAR1 1809 antibody for 1 h at
4°C; under these conditions, only PAR1 residing on the cell surface
bound antibody. Cells were washed and then incubated in the
absence or presence of agonist for various times at 37°C. Cells were
fixed and processed for microscopy as previously described (Trejo et
al., 2000). Endogenous SNX1, lamp1, and EEA1 was detected by
incubation with appropriate antibodies for 1 h at 25°C. Myc-tagged
SNX1 or SNX1 C terminus was detected with mouse, rabbit, or
chicken anti-myc antibodies. Cells were then washed and incubated
with species-specific fluorophore-conjugated secondary antibodies
for an additional hour at 25°C and were then processed for confocal
microscopy. Images were collected using an Fluoview 300 laser
scanning confocal imaging system (Olympus, Melville, NY) config-
ured with an IX70 fluorescence microscope fitted with a PlanApo
60  oil objective (Olympus). Fluorescent images, X-Y section at 0.28
M, were collected sequentially at 800  600 resolution with 2
optical zoom. The final composite image was created using Adobe
Photoshop 6.0 (Adobe Systems, Mountain View, CA). The number
of cells containing internalized PAR1 was quantitated by counting
cells that had greater than 10 PAR1-positive endosomes and
costained for either SNX1 or SNX1 C terminus. All pcDNA-trans-
fected cells containing PAR1-positive endosomes were counted. In
these experiments, sample conditions were blindly coded and
counted by two individuals. The values shown represent at least 25
cells counted per condition in an experiment that was repeated
three separate times. The data (mean  SEM) are expressed as a
percentage of PAR1-positive cells that costained for SNX1 or SNX1
C terminus.
RESULTS
Agonist-induced Colocalization of PAR1 with
Endogenous SNX1 in HeLa Cells
Toward understanding the molecular mechanisms by which
activated PAR1 is internalized and sorted to lysosomes, we
investigated whether PAR1 associated with SNX1 in HeLa
cells. We have used the HeLa cell line because SNX1 is
endogenously expressed (Kurten et al., 1996), and agonist-
triggered internalization and lysosomal sorting of PAR1, as
seen in fibroblasts and endothelial cells, also occurs in HeLa
cells (Trejo et al., 2000). We stably expressed PAR1 contain-
ing an amino-terminal FLAG epitope in these cells and
assessed agonist-induced colocalization by confocal micros-
copy using anti-FLAG and anti-SNX1 antibodies. Antiserum
raised against SNX1 recognized both endogenous and re-
combinant SNX1 in HeLa cells (unpublished results).
Confocal microscopy studies of PAR1 and endogenous
SNX1 revealed an agonist-induced colocalization of these
molecules. HeLa cells stably expressing PAR1 were first
incubated with anti-PAR1 antibody for 1 h at 4°C; under
these conditions, only receptors residing on the cell surface
bind antibody (unpublished results). Cells were then
warmed to 37°C in the presence or absence of agonist
SFLLRN for 10 min, fixed, and immunostained for PAR1
and endogenous SNX1. In untreated control cells, PAR1 was
found localized predominantly to the cell surface, whereas
endogenous SNX1 was distributed throughout the cyto-
plasm in punctate structures and failed to colocalize with
PAR1 (Figure 1, Control). By contrast, the addition of agonist
peptide SFLLRN caused marked redistribution of PAR1 into
endocytic vesicles, and endogenous SNX1 showed substan-
tial colocalization with activated PAR1 (Figure 1, SFLLRN);
60% of PAR1-positive endosomes costained for SNX1.
Thus, after agonist-induced internalization, PAR1 colocal-
izes with endogenous SNX1 in an endosomal compartment.
In Vitro Interaction of PAR1 and SNX1
To assess PAR1 interaction with SNX1, we first performed in
vitro biochemical binding or “pull-down” assays. In these
experiments, equal amounts of GST-SNX1 fusion protein
(and GST protein alone) absorbed to glutathione-Sepharose
beads were incubated with membranes prepared from HeLa
cells stably expressing PAR1 or untransfected control cells.
An immunoblot of proteins eluted from GST-SNX1 incu-
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bated with membranes prepared from PAR1-expressing
cells revealed one major transfection-dependent protein mi-
grating at 68 kDa, whereas an immunoblot of proteins
eluted from GST alone failed to detect this protein (Figure
2A, lanes 1 and 2). This 68 kDa band is consistent with the
molecular weight of PAR1 detected in lysates prepared from
transfected HeLa cells (Figure 2A, lane 5) and with that
previously reported for PAR1 (Ishii et al., 1993; Trejo and
Coughlin, 1999). To test whether SNX1 associates only with
receptors that efficiently down-regulate, we examined
whether GST-SNX1 interacted with the P2Y2 purinergic
GPCR. The P2Y2 receptor is activated by extracellular nucle-
otides, internalized, and efficiently recycled to the cell sur-
face like most classic GPCRs (Sromek and Harden, 1998).
Neither GST-SNX1 nor GST alone interacted with the P2Y2
receptor under the same conditions in which GST-SNX1 was
associated with PAR1 (Figure 2B, lanes 1 and 2). An aliquot
of membrane lysate representing 10% input showed sub-
stantial amount of P2Y2 receptor present in the membrane
preparations (Figure 2B, lane 5). These observations suggest
that in vitro SNX1 is capable of interacting with PAR1, a
receptor that undergoes efficient agonist-induced down-reg-
ulation.
SNX1 Association with PAR1 Is Enhanced
following Activation in HeLa Cells
Next, we examined whether activated PAR1 and SNX1 as-
sociate in vivo by coimmunoprecipitation. HeLa cells tran-
siently cotransfected with FLAG-tagged PAR1 and myc-
tagged SNX1 were incubated with or without agonist
peptide SFLLRN for 10 min at 37°C. Cells were lysed and
immunoprecipitated with M2 anti-FLAG antibody and the
presence of SNX1 was detected by immunoblotting. In un-
treated control cells expressing myc-SNX1, a substantial
amount of PAR1 was immunoprecipitated; however, only a
small amount of SNX1 coimmunoprecipitated with the re-
ceptor, suggesting that unactivated receptor weakly associ-
ates with SNX1 (Figure 3, lane 1). By contrast, immuno-
precipitates from agonist-treated cells revealed that substan-
tially more SNX1 associated with activated PAR1 (Figure 3,
lane 2). Neither SNX1 nor PAR1 was immunoprecipitated
with isotype-matched control IgG (Figure 3, lanes 3 and 4).
These observations strongly suggest that in vivo PAR1 acti-
vation enhances association with SNX1.
Overexpression of SNX1 C-terminal Domain
Inhibits Agonist-induced Degradation of PAR1
SNX1 contains a phox homology domain predicted to bind
phosphatidylinositol-3-phosphate, and a C-terminal coiled-
coil region (Kurten et al., 1996; Haft et al., 1998; Wu and
Lemmon, 2001). To assess SNX1 function in PAR1 traffick-
ing, we first asked if various deletion mutants of SNX1
would block agonist-induced PAR1 degradation. Accord-
ingly, we generated several SNX1 deletion mutants, as illus-
trated in Figure 4A. HeLa cells transiently cotransfected
with FLAG-PAR1 and myc-tagged SNX1 deletion mutants
were treated with agonist peptide SFLLRN for 60 min at
37°C. Cells were lysed, immunoprecipitated with anti-FLAG
antibody, and the amount of receptor protein remaining was
examined by immunoblotting with anti-PAR1 antibody. In
cells cotransfected with SNX1 or empty vector, exposure to
agonist decreased PAR1 protein by 70% (Figure 4B and C,
lanes 1–4). These findings are consistent with the extent of
PAR1 degradation previously reported in HeLa and other
cell types (Trejo and Coughlin, 1999; Trejo et al., 2000). PAR1
was similarly degraded in cells expressing the SNX1 N
terminus (Figure 4B and C, lanes 5 and 6). PAR1 degradation
was slightly inhibited in cells expressing the N-PX and PX-
C-terminal regions of SNX1 (Figure 4B and C, lanes 7–10). In
striking contrast, agonist-induced degradation of PAR1 was
markedly inhibited in cells cotransfected with SNX1 C-ter-
minal domain; only a 16% decrease in PAR1 receptor
protein was detected after 60 min of agonist exposure (Fig-
ure 4B and C, lanes 11 and 12). Thus, the ability of SNX1 C
terminus to inhibit PAR1 degradation suggests that sorting
Figure 1. Agonist-induced colo-
calization of PAR1 with endoge-
nous SNX1 in HeLa cells. HeLa
cells stably expressing PAR1 were
incubated in the absence (Con-
trol) or presence of 50 M
SFLLRN for 10 min at 37°C. Cells
were fixed, permeabilized, and
immunostained for PAR1 (green)
and endogenous SNX1 (red) and
were examined by confocal mi-
croscopy. These images are repre-
sentative of many cells examined
in three separate experiments.
Note the prominent agonist-in-
duced colocalization (yellow) of
PAR1 and SNX1 in the merged im-
age. Scale bar represents 10 m.
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of activated PAR1 to a degradative pathway is SNX1 depen-
dent.
SNX1 C-Terminal Coiled-Coil Domain Can
Assemble with Full-Length SNX1
SNX1 C terminus encodes a coiled-coil domain that may
assemble with endogenous SNX1 to function as a dominant-
negative when expressed in HeLa cells. To determine
whether the SNX1 C-terminal coiled-coil domain was suffi-
cient for assembly with full-length SNX1, we tested for
association by coimmunoprecipitation. HeLa cells were tran-
siently cotransfected with full-length HA-tagged SNX1 and
various myc-tagged SNX1 deletion mutants. Cells were
lysed, immunoprecipitated with anti-HA antibody, and the
presence of myc-tagged SNX1 deletion mutants was de-
tected by immunoblotting. A full-length myc-tagged SNX1
coimmunoprecipitated with HA-SNX1, suggesting that
SNX1 can self associate when expressed in HeLa cells (Fig-
ure 5, lane 2). These findings are consistent with previous
Figure 2. SNX1 associates with PAR1 in vitro. (A) GST-SNX1 fusion
protein or GST protein alone absorbed to glutathione-Sepharose beads
was incubated with equal amounts of membranes prepared from
PAR1-transfected HeLa cells or untransfected (UT) control cells. Bound
proteins were eluted, resolved by SDS-PAGE, and immunoblotted
with anti-PAR1 antibody (upper panel). An aliquot of membranes
prepared from PAR1-expressing HeLa cells or UT control cells repre-
senting 10% of input is shown in lanes 5 and 6, respectively. The
nonspecific bands detected in pull-downs of UT control cells are
shown in lanes 3 and 4. Similar findings were observed in four separate
experiments. Note the detection of one prominent transfection-depen-
dent 68 kDa protein in GST-SNX1 pull-down shown in lane 2. (B)
GST-SNX1 or GST protein alone absorbed to glutathione-Sepharose
beads was incubated with membranes prepared from HeLa cells ex-
pressing HA-tagged P2Y2 receptor or UT control cells. Bound proteins
were eluted and immunoblotted with anti-HA antibody (upper panel).
An aliquot of membranes representing 10% of input is shown in lane
5 (upper panel). Similar results were observed in three separate exper-
iments. Note the failure of GST-SNX1 to bind the P2Y2 receptor. The
total amount of GST-SNX1 and GST protein loaded in various lanes
was visualized by Ponceau S staining (bottom panels).
Figure 3. Coimmunoprecipitation of SNX1 with activated PAR1 in
HeLa cells. HeLa cells transiently cotransfected with FLAG-tagged
PAR1 and myc-SNX1 were treated in the absence () or presence
() of 50 M SFLLRN for 10 min at 37°C. Cells were lysed and equal
amounts of lysates were immunoprecipitated with M2 anti-FLAG
antibody or isotype-matched control IgG. Immunoprecipitates were
immunoblotted for SNX1 using anti-myc-peroxidase antibody (up-
per panel) or for PAR1 using 1809 antibody (middle panel). SNX1
expression in total cell lysates representing 12% of input and was
detected with anti-myc antibody (bottom panel). Similar results
were observed in six independent experiments. Note the prominent
agonist-induced association of SNX1 with PAR1.
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studies demonstrating SNX1 self-assembly in COS cells
(Haft et al., 1998). By contrast, the N terminus of SNX1 failed
to coimmunoprecipitate with HA-SNX1 (Figure 5, lane 3).
Both the N-PX and PX-C-terminal regions of SNX1 coimmu-
noprecipitated with full-length SNX1 (Figure 5, lanes 4 and
5), suggesting that the PX domain can mediate assembly
with SNX1. Interestingly, the C-terminal coiled-coil domain
also was robustly coimmunoprecipitated with full-length
HA-SNX1 (Figure 5, lane 6). Thus, SNX1 C-terminal coiled-
coil domain alone is sufficient to assemble with full-length
SNX1, suggesting that the C terminus may interact with
endogenous SNX1 to function in a dominant-negative
manner.
Effect of SNX1 C Terminus on Agonist-induced
PAR1 and P2Y2-Receptor Internalization
To determine whether SNX1 C-terminal domain blocked
PAR1 degradation by inhibiting receptor internalization, we
examined agonist-induced loss of cell-surface PAR1. HeLa
cells transiently cotransfected with FLAG-tagged PAR1 and
SNX1 C terminus or empty vector were treated with agonist
peptide SFLLRN for various times at 37°C. After incuba-
tions, cells were fixed and the amount of PAR1 remaining on
the cell surface was quantitated by cell-surface ELISA and
used as a measure of receptor internalization. In these ex-
periments, the initial level of PAR1 detected on the cell
surface before incubation, the 0-min time point, was similar
for each transfection condition. In cells cotransfected with
PAR1 and empty vector, agonist peptide SFLLRN induced
rapid internalization of PAR1 from the plasma membrane
within 10 min (Figure 6A). PAR1 continued to slowly inter-
nalize with an 45% loss of surface PAR1 detected after 30
min of agonist exposure (Figure 6A). In cells cotransfected
with PAR1 and SNX1 C terminus, the addition of agonist
caused a similar decrease in the amount of surface PAR1
over time (Figure 6A). The overexpression of SNX1 also did
not effect the rate of agonist-induced PAR1 internalization
(unpublished results). In cells cotransfected with P2Y2 re-
ceptor and SNX1 C-terminus or empty vector the addition of
agonist ATP caused a more modest decrease in cell surface
P2Y2 receptor that reached near steady state by 10 min
(Figure 6B). The agonist-induced loss of P2Y2 receptor is
consistent with internalization and recycling of this receptor.
Thus, the marked inhibitory effect of SNX1 C terminus on
PAR1 degradation is unlikely to involve regulation at the
level of receptor internalization.
Overexpression of SNX1 C-terminal Domain Causes
Agonist-induced PAR1 Accumulation in Endosomes
To test whether SNX1 C terminus blocked delivery of PAR1
from endosomes to lysosomes, we examined PAR1 accumu-
lation after prolonged agonist treatment. HeLa cells stably
expressing FLAG-tagged PAR1 were transiently transfected
with SNX1 or SNX1 C terminus, and then treated with
agonist SFLLRN for either 10 or 30 min at 37°C. Cells were
fixed, immunostained for PAR1 and SNX1, and examined by
confocal microscopy. In cells transfected with SNX1, agonist
treatment induced substantial redistribution of PAR1 into
endocytic vesicles at 10 min (Figure 7A, e and f). Activated
PAR1 was similarly internalized into endosomes in SNX1 C
terminus transfected cells after 10 min of agonist exposure
(Figure 7A, g and h), consistent with the ELISA experiments
shown in Figure 6. An adjacent cell that lacked SNX1 C
terminus expression also showed substantial agonist-in-
duced PAR1 internalization at 10 min (Figure 7A, g and h,
arrowhead). However, after 30 min of agonist exposure,
Figure 4. Overexpression of
SNX C terminus markedly inhib-
its agonist-induced degradation
of PAR1. (A) Domain structure
model of SNX1 and various dele-
tion mutants. The phox homol-
ogy domain is represented as
“PX” and the coiled-coiled region
is shown as “CC.” (B) HeLa cells
transiently cotransfected with
PAR1 and SNX1, SNX1 mutants,
or pcDNA vector were incubated
in the absence () or presence
() of 50 M SFLLRN for 60 min
at 37°C. Cells were lysed, immu-
noprecipitated with anti-FLAG
antibody, and the amount of
PAR1 remaining was detected by
immunoblot with anti-PAR1 an-
tibody and quantitated by Flu-
or-S Imager (upper panel). The
expression of SNX1 and various
deletion mutants in cell lysates
was detected with anti-myc anti-
body (lower panel). Results in the bar graph are expressed as a percentage of PAR1 measured in untreated control lysates and were
determined for each transfection condition. The data are represented as the mean  SEM of three separate experiments in which duplicate
determinations were made. Note the marked inhibition of agonist-induced PAR1 degradation in cells expressing SNX1 C-terminal coiled-coil
domain.
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PAR1-positive endosomes were no longer apparent in
SNX1-transfected cells (Figure 7A, i and j), consistent with
agonist-induced internalization and sorting of PAR1 to a
degradative pathway. PAR1 was similarly degraded after 30
min of agonist exposure in an adjacent cell lacking SNX1
expression (Figure 7A, i and j, open arrow). By contrast, in
SNX1 C terminus-transfected cells, PAR1-positive endo-
somes were apparent and easily detected even after 30 min
of agonist incubation (Figure 7A, k and l). Quantitative
analysis of hundreds of examined cells was consistent with
an inhibitory effect of SNX1 C terminus on lysosomal sorting
of PAR1. After 10 min of agonist incubation, 80% of cells
transfected with SNX1, SNX1 C terminus, or empty vector
showed substantial amount of PAR1-positive endosomes
(Figure 7B). However, after 30 min of agonist exposure,
SNX1- and mock-transfected cells showed almost complete
loss of PAR1 endosomes; only 2 and 6% of transfected cells
costained for PAR1, respectively (Figure 7B). In striking
contrast, a significant fraction of cells expressing SNX1 C
terminus showed marked accumulation of PAR1-positive
endosomes even after 30 min of agonist exposure; 58% of
SNX1 C terminus-expressing cells costained for PAR1 (Fig-
ure 7B). Thus, PAR1 accumulates in endosomes and fails to
efficiently sort to a degradative pathway in a significant
fraction of cells overexpressing SNX1 C-terminal domain.
SNX1 C-Terminal Coiled-Coil Domain Does Not
Generally Inhibit Lysosomal Transport
Lamp1 is transported to lysosomes directly via the trans-
Golgi network or indirectly via the cell surface within hours
(Fukuda, 1991). To exclude the possibility that overexpres-
sion of SNX1 C terminus had pleiotrophic inhibitory effects
Figure 5. SNX1 C-terminal coiled-coil domain associates with full-
length SNX1. HeLa cells transiently cotransfected with HA-SNX1
and myc-SNX1 deletion mutants were lysed and immunoprecipi-
tated with anti-HA antibody. Immunoprecipitates were immuno-
blotted for full-length myc-SNX1 or deletion mutants using anti-
myc-peroxidase antibody (upper panel). The expression of HA-
SNX1 and myc-SNX1 deletion mutants in total cell lysates is shown
in the middle and lower panels, respectively. Note the prominent
association of SNX1 C-terminal coiled-coil domain with full-length
SNX1, lane 6. The data are representative of two separate experi-
ments. Figure 6. Effect of SNX1 C-terminal domain on agonist-triggeredPAR1 and P2Y2 receptor internalization. (A) HeLa cells transiently
cotransfected with FLAG-tagged PAR1 and either SNX1 C terminus
or pcDNA vector were incubated in the absence or presence of 50
M SFLLRN for various times at 37°C. (B) HeLa cells transiently
cotransfected with P2Y2 receptor and either SNX1 C terminus or
pcDNA vector were treated in the absence or presence of 100 M
ATP for various times at 37°C. Cells were then fixed and the amount
of PAR1 or P2Y2 receptor remaining on the cell surface was detected
by cell surface ELISA. The initial level of PAR1 or P2Y2 receptor
expressed on the cell surface before incubation at 37°C (0-min time
point) was similar for each transfection condition. Results are ex-
pressed as a fraction of total antibody bound to untreated controls.
The data (mean  SEM) are representative of three separate exper-
iments in which triplicate determinations were made.
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on vesicular transport to lysosomes, we examined the dis-
tribution of lamp1. HeLa cells transiently transfected with
SNX1 C terminus or empty vector were immunostained for
lamp1 and SNX1 C terminus and were examined by confocal
microscopy. In mock-transfected cells, lamp1 localized pre-
dominantly to a heterogeneous population vesicles distrib-
uted throughout the cytoplasm (Figure 8, a and b), consis-
tent with lamp1 distribution previously reported (Futter et
al., 1996). SNX1 C terminus was detected predominantly in
a punctate pattern (Figure 8, c), similar to that observed for
endogenous SNX1 (Figure 1). The distribution of lamp1 was
strikingly similar in SNX1 C terminus- and mock-transfected
cells (Figure 8, compare b and d). Moreover, incubation with
LysoTracker Red, a membrane-permeable probe that accu-
mulates in acidic organelles, revealed a distinct population
of vesicles in SNX1 C terminus-expressing cells similar to
that observed in mock-transfected control cells (unpublished
results). Thus, overexpression of SNX1 C terminus does not
appear to inhibit normal biogenesis or maintenance of the
lysosomal compartment, suggesting that the SNX1 C-termi-
nal domain does not have general inhibitory effects on ve-
sicular transport to lysosomes.
SNX1 C Terminus Overexpression Leads to
Accumulation of Agonist-induced Internalized PAR1
in EEA1-Positive Early Endosomes
To begin to understand the mechanism by which SNX1 C
terminus disrupts sorting of PAR1 from endosomes to lyso-
somes, we examined PAR1 colocalization with EEA1. EEA1
is a core component of the endosome docking and fusion
machinery and a specific marker of early endosomes
Figure 7. Agonist-induced PAR1 accumulation in endosomes in
SNX1 C terminus transfected cells. (A) PAR1-expressing HeLa cells
transiently transfected with SNX1 or SNX1 C terminus were treated
in the absence (Control) or presence of 50 M SFLLRN for either 10
or 30 min at 37°C. Cells were fixed, immunostained for PAR1 and
SNX1 or SNX1 C terminus, and imaged by confocal microscopy.
Note the presence of PAR1-positive endosomes in SNX1 C termi-
nus-transfected cells even after 30 min of agonist exposure (k and l),
but the absence of such endosomes in SNX1 transfected cells (i and
j). (B) The results of quantitative analysis are expressed as a per-
centage of cells that showed PAR1-positive endosomes and
costained for either SNX1 or SNX1 C terminus. All cells containing
PAR1-positive endosomes were counted in pcDNA vector-trans-
fected controls. The data (mean  SEM) are representative of three
separate experiments in which at least 25 determinations were
made. Scale bar represents 10 m.
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(Christoforidis et al., 1999). In untreated control cells, PAR1
was found predominantly on the cell surface by confocal
microscopy and did not colocalize with EEA1 (Figure 9A,
Control). After 10 min of agonist treatment, PAR1 was re-
distributed to endocytic vesicles and markedly colocalized
with EEA1; 80% of PAR1-positive endosomes costained
for EEA1 (Figure 9A, SFLLRN 10 min). By contrast, after 30
min of agonist treatment, PAR1-containing endosomes were
no longer apparent (Figure 9A, SFLLRN 30 min), whereas
EEA1 localization was unperturbed. These findings are con-
sistent with sorting of PAR1 from early endosomes to a
degradative compartment after prolonged agonist exposure.
Interestingly, endogenous SNX1 also showed substantial
colocalization with EEA1 (Figure 9B). Together, these find-
ings suggest that after agonist-induced internalization,
PAR1 and SNX1 colocalize in an EEA1-positive endosomal
compartment, PAR1 is then sorted away from this compart-
ment, delivered to lysosomes, and degraded.
Next, we examined colocalization of internalized PAR1
and EEA1 in cells transfected with SNX1 C terminus after
prolonged agonist treatment. In untreated control cells ex-
pressing SNX1 C terminus, PAR1 was predominantly local-
ized to the cell surface and failed to colocalize with EEA1
(Figure 10, Control). After 10 min of agonist exposure, PAR1
and EEA1 showed substantial colocalization in cells express-
ing SNX1 C terminus (Figure 10, SFLLRN 10 min), consistent
with the results described above. Strikingly, after 30 min of
agonist exposure, PAR1-positive endosomes were easily de-
tected and showed marked colocalization with EEA1 in
SNX1 C terminus-expressing cells (Figure 10, SFLLRN 30
min). Thus, after activation, PAR1 is internalized to an
EEA1-positive early endosomal compartment and fails to
efficiently transit this compartment in cells overexpressing
SNX1 C-terminal domain.
DISCUSSION
The internalization and lysosomal degradation of activated
PAR1 is critical for termination of receptor signaling (Trejo et
al., 1998; Trejo and Coughlin, 1999). The molecular mecha-
nisms responsible for intracellular targeting of PAR1 to ly-
sosomes are not known. In this study, we demonstrate that
SNX1 associates with PAR1 and regulates lysosomal sorting
of the receptor. Our biochemical binding assays demonstrate
that SNX1 can associate with PAR1 in vitro. Moreover, con-
focal microscopy studies of HeLa cells revealed that after
agonist-induced internalization, PAR1 colocalizes with en-
dogenous SNX1 in an intracellular endosomal compartment.
Consistent with these results, analysis of coimmunoprecipi-
tates showed an enhanced agonist-induced association of
PAR1 with SNX1 in vivo. By contrast, the P2Y2 receptor, a
classic GPCR that internalizes and efficiently recycles, failed
to interact with SNX1. Whether these findings suggest spec-
ificity for SNX1 binding to receptors that efficiently down-
regulate versus those that efficiently recycle and only slowly
down-regulate remains to be determined.
The association of SNX1 with PAR1 is enhanced following
activation. This may be due to an agonist-induced modifi-
cation of PAR1 or redistribution of PAR1 to an intracellular
compartment containing SNX1. Phosphorylation of PAR1’s
cytoplasmic carboxyl tail serine and threonine residues is
required for internalization and down-regulation of the re-
ceptor in many cell types (Shapiro et al., 1996; Paing et al.,
2002). Thus, it is possible that PAR1 phosphorylation per se
is sufficient to facilitate association with SNX1 and thereby
regulates sorting of the receptor. PAR1 phosphorylation
could also mark the receptor for ubiquitination and this may
mediate lysosomal sorting of the receptor by facilitating
interaction with SNX1. It was recently shown that ubiquiti-
nation of the 2-adrenergic and CXCR4-chemokine GPCR is
required for lysosomal degradation in mammalian cells
(Marchese and Benovic, 2001; Shenoy et al., 2001). It is not
known whether activated PAR1 is modified to facilitate
association with SNX1 or whether activated PAR1 is simply
targeted to an intracellular compartment in which SNX1
resides. Regardless, our findings strongly suggest that after
agonist-induced internalization, association of PAR1 with
SNX1 is enhanced.
SNX1 was previously demonstrated to function in the
degradation of the EGF-R (Kurten et al., 1996), a receptor that
undergoes efficient down-regulation. This finding strongly
suggests a role for SNX1 in endosome-to-lysosome traffick-
ing and raised the possibility that SNX1 might function in
sorting of PAR1 to lysosomes. A SNX1 deletion mutant
inhibited EGF-R degradation, suggesting that deletion mu-
tants could function in a dominant-negative manner (Kurten
et al., 1996). We found that a deletion mutant of SNX1
encoding the C-terminal coiled-coil domain markedly inhib-
ited agonist-induced PAR1 degradation, whereas internal-
Figure 8. Effect of SNX1 C terminus overexpression on lamp1
distribution. HeLa cells were transiently transfected with myc-
tagged SNX1 C terminus or pcDNA vector. At 48 h after transfec-
tion, cells were fixed, immunostained for SNX1 C terminus (red)
and lamp1 (green), and examined by confocal microscopy. Note the
similar distribution of lamp1 in SNX1 C terminus and pcDNA-
transfected cells shown in b and d. The images are representative of
many cells examined in two separate experiments. Scale bar denotes
10 m.
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ization remained virtually intact. Consistent with these re-
sults, sorting of internalized PAR1 from EEA1-positive early
endosomes to lysosomes is inhibited in a significant fraction
of cells overexpressing SNX1 C terminus. The localization of
PAR1 and endogenous SNX1 to EEA1-positive endosomes
provides further evidence in support of a role for SNX1 in
trafficking of PAR1 at an early endosomal stage. In cells
overexpressing SNX1 C terminus, the distribution of lamp1
was unperturbed, suggesting that general vesicular trans-
port to lysosomes remained intact. Moreover, the EEA1-
positive early endosomal compartment was also unaltered
in cells overexpressing SNX1 C terminus, further excluding
the possibility that SNX1 C terminus had pleiotrophic inhib-
itory effects on vesicular transport. Thus, the ability of SNX1
C-terminal coiled-coil domain to inhibit sorting of internal-
ized PAR1 to a degradative pathway strongly suggests that
lysosomal sorting of the receptor is SNX1 dependent.
SNX1 is a peripheral membrane protein that can self-
assemble or assemble with SNX2, a closely related homolog,
to form homo-oligomers or hetero-oligomers both in vitro
and in vivo (Haft et al., 1998; Kurten et al., 2001). Interest-
ingly, Vps5p, the yeast ortholog of SNX1, also displays
self-assembly activity (Seaman et al., 1998). The SNX1 C-
terminal coiled-coil domain was recently shown to be im-
portant for the localization of SNX1 to endosomes in HeLa
cells (Teasdale et al., 2001). Moreover, we demonstrate that
the C-terminal coiled-coil domain is sufficient to assemble
with full-length SNX1. Indeed, coiled-coils are one of the
principal subunits for oligomerization of a variety of pro-
teins (Burkhard et al., 2001). These findings suggest that the
C-terminal coiled-coil region of SNX1 might specify interac-
tion with itself or another membrane-associated protein to
mediate assembly and perhaps endosomal localization.
Thus, it is conceivable that SNX1 C terminus coiled-coil
domain acts as a dominant-negative of endogenous SNX1
function by disrupting such interactions and thereby inhibits
sorting of internalized PAR1 from endosomes to lysosomes.
The function of SNX1 in intracellular protein trafficking in
mammalian cells is poorly understood. However, many
membrane trafficking pathways are conserved throughout
evolution, suggesting that studies of yeast Vps5p, an or-
tholog of SNX1 and SNX2, could offer insight regarding the
function of SNX1 and SNX2 in mammalian cells. Indeed,
SNX1, SNX2, and Vps5p display self-assembly activity,
which may provide the mechanical force necessary to drive
vesicle budding (Haft et al., 1998; Seaman et al., 1998; Kurten
et al., 2001). In support of this idea, Vps5p has been localized
to the rims of budding vesicles on prevacuolar endosomes
by electron microscopy (Seaman et al., 1998). Moreover, bio-
chemical and genetic evidence suggest that Vps5p is part of
a multimeric complex, termed “retromer,” that functions in
retrieval of sorting proteins from prevacuolar endosomes to
the Golgi (Horazdovsky et al., 1997; Nothwehr and Hindes,
1997; Seaman et al., 1998). This process is required for effi-
Figure 9. PAR1 and endogenous SNX1
colocalize with EEA1-positive early en-
dosomes. (A) HeLa cells expressing
PAR1 were treated in the absence (Con-
trol) or presence of 50 M SFLLRN for
10 or 30 min at 37°C. Cells were fixed,
immunostained for PAR1 (green) and
EEA1 (red), and imaged by confocal mi-
croscopy. Note the prominent agonist-
induced colocalization (yellow) of PAR1
and EEA1 after 10 min of agonist expo-
sure shown in the merged image and
the loss of PAR1-positive endosomes af-
ter 30 min of agonist exposure. (B) HeLa
cells were immunostained for endoge-
nous SNX1 (green) and EEA1 (red) and
were examined by confocal microscopy.
Endogenous SNX1 and EEA1 colocaliza-
tion (yellow) is shown in the merged im-
age. The cells imaged are representative
of many cells examined in four separate
experiments. Scale bar denotes 10 m.
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cient sorting to the vacuole because the loss of any compo-
nent of the retromer complex leads to mislocalization of
sorting receptors and mistargeting of proteins destined to
the vacuole. SNX1 has also been shown to be part of a large
multimeric complex in mammalian cells, suggesting a sim-
ilar function in cargo selection and vesicle formation per-
haps as part of the endosome-to-lysosome sorting machin-
ery (Haft et al., 2000). Consistent with this idea, we
demonstrate endogenous SNX1 localization to EEA1-posi-
tive early endosomes, and others have shown that ectopi-
cally expressed SNX1 localizes to EEA1 endosomes (Kurten
et al., 2001; Teasdale et al., 2001). Moreover, SNX1 contains a
phox homology domain that is predicted to bind phospha-
tidylinositol-3-phosphate, which is highly enriched in endo-
somal membranes (Wu and Lemmon, 2001). Components of
the yeast retromer complex can directly associate with the
cytoplasmic tail of cargo proteins (Nothwehr et al., 2000);
whether SNX1 or another component of the mammalian
“retromer” complex interacts directly with PAR1 remains to
be determined.
In summary, we used PAR1 as a model system to inves-
tigate the molecular mechanisms responsible for GPCR
down-regulation. Activated PAR1 is internalized via an ar-
restin-independent but dynamin- and clathrin-dependent
pathway and is then efficiently sorted to lysosomes (Trejo et
al., 2000; Paing et al., 2002). SNX1 was originally identified as
a protein that interacted with the EGF-R cytoplasmic tail and
was shown to mediate EGF-R down-regulation (Kurten et
al., 1996). In these studies, we demonstrate that SNX1 asso-
ciates with PAR1 and is involved in down-regulation of the
receptor. These studies provide the first example of a protein
involved in lysosomal sorting of a GPCR in mammalian
cells. In contrast, 2-adrenergic receptor interaction with
ezrin-radixin-moesin-binding phosphoprotein-50/Na-H
exchanger regulator factor (EBP50/NHERF) family proteins
has been suggested to regulate efficient recycling of GPCRs
(Hall et al., 1998; Cao et al., 1999). Moreover, we demonstrate
that endogenous SNX1 is localized to early endosomes and
a dominant-negative SNX1 C terminus blocks sorting of
PAR1 from early endosomes to lysosomes. These findings
bring new insight into how SNX1 might function in protein
trafficking in mammalian cells. The challenge now becomes
to elucidate the mechanism by which SNX1 regulates sorting
of PAR1 from early endosomes to lysosomes, an event crit-
ical for termination of receptor signaling (Trejo et al., 1998;
Trejo and Coughlin, 1999).
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